Brian Druker, recipient of a 2009 Lasker~DeBakey Clinical Medical Research Award, discusses imatinib as a paradigm for targeted cancer therapies in a three-part seminar produced by iBiology. Visit iBiology to view more seminars and short talks on science topics.
Visit iBiology to view seminars, stories, and find advice on science careers. iBiology was founded in 2006 by Lasker laureate Ron Vale.
Part One
Part Two
Part Three
